NF2 and neoplasm: In 2014, Shapiro and colleagues [90] reported that a beneficial effect of an FAK inhibitor, VS-4718 (alternatively PND-1186), on MM cells lacking merlin expression was the increased sensitivity of MM cells to VS-4718 in vitro and in tumor xenograft models.